En general, las crticas son bastante positivas y sugieren una alta aceptacin del producto dentro del mercado actual sin menciones relevantes acerca de aspectos negativos contundentes relacionados directamente con su funcionamiento o calidad
Jones B, Buenaventura T, Kanda N, et al
CKD is predicted to be the fifth largest cause of mortality by 2040 and so slowing progression of CKD and reducing cardiovascular mortality will reduce NHS spend and is hugely important for patients, Clare Morlidge, a consultant renal pharmacist and deputy chair of the UK Renal Pharmacy Group, tells The Pharmaceutical Journal , adding that semaglutide is another medication in the cupboard for slowing the progression of CKD
Disulfide bonds formed by the oxidation of two cysteine residues to give cystine are essential for the stability of secreted and plasma-membrane proteins (reviewed in Trivedi et al , 2009)
M.GonzalezG
However, it is not clear how GLP-1 RA regulates ER stress